HomeShop › Tirzepatide T30 (30mg)

GLP

Tirzepatide T30 (30mg)

Dual-pathway metabolic research.

Tirzepatide T30 (30mg) - Taylor Tides vial $275

An investigational dual GIP/GLP-1 receptor agonist, studied for metabolic health. Not FDA-approved.

Investigational research compound - not FDA-approved. For research purposes only.

i

For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Taylor Tides is not a medical provider - always speak with a licensed healthcare professional before making decisions about your health.

You may also be interested in

Wellness should feel clear, personal, and supported.

Have a question about this catalog product? Reach out. I read every message myself.

Get in touch →